Page last updated: 2024-12-10
cupric ferrocyanide
Description
Research Excerpts
Clinical Trials
Roles
Classes
Pathways
Study Profile
Bioassays
Related Drugs
Related Conditions
Protein Interactions
Research Growth
Market Indicators
Cross-References
ID Source | ID |
---|---|
PubMed CID | 3081430 |
MeSH ID | M0117284 |
Synonyms (15)
Synonym |
---|
dicopper hexacyanoferrate |
unii-871d97g82z |
871d97g82z , |
ferrate(4-), hexakis(cyano-c)-, copper(2+) (1:2) |
einecs 237-080-3 |
ai3-28803 |
cupric ferrocyanide |
13601-13-3 |
cupric ferrocyanide [mi] |
hatchett's brown |
cupric hexacyanoferrate(ii) |
dicopper;iron(2+);hexacyanide |
copper(2+) iron(2+) cyanide (2/1/6) |
DTXSID70929219 |
Q18211787 |
Research Excerpts
Dosage Studied
Excerpt | Relevance | Reference |
---|---|---|
"3μg/L, the dosage of CuFC was 40mg/L and the adsorption time was 20min." | ( Removal of cesium from simulated liquid waste with countercurrent two-stage adsorption followed by microfiltration. Gu, P; Han, F; Zhang, GH, 2012) | 0.38 |
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]
Research
Studies (23)
Timeframe | Studies, This Drug (%) | All Drugs % |
---|---|---|
pre-1990 | 6 (26.09) | 18.7374 |
1990's | 5 (21.74) | 18.2507 |
2000's | 5 (21.74) | 29.6817 |
2010's | 5 (21.74) | 24.3611 |
2020's | 2 (8.70) | 2.80 |
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] |
Market Indicators
Research Demand Index: 27.21
According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be moderate demand-to-supply ratio for research on this compound.
| This Compound (27.21) All Compounds (24.57) |
Study Types
Publication Type | This drug (%) | All Drugs (%) |
---|---|---|
Trials | 0 (0.00%) | 5.53% |
Reviews | 0 (0.00%) | 6.00% |
Case Studies | 0 (0.00%) | 4.05% |
Observational | 0 (0.00%) | 0.25% |
Other | 23 (100.00%) | 84.16% |
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] |